Fluorine in PDB 2r3i: Crystal Structure of Cyclin-Dependent Kinase 2 with Inhibitor
Enzymatic activity of Crystal Structure of Cyclin-Dependent Kinase 2 with Inhibitor
All present enzymatic activity of Crystal Structure of Cyclin-Dependent Kinase 2 with Inhibitor:
2.7.11.22;
Protein crystallography data
The structure of Crystal Structure of Cyclin-Dependent Kinase 2 with Inhibitor, PDB code: 2r3i
was solved by
T.O.Fischmann,
A.W.Hruza,
V.M.Madison,
J.S.Duca,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
21.80 /
1.28
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
52.930,
71.710,
71.760,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
17.7 /
20.2
|
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Crystal Structure of Cyclin-Dependent Kinase 2 with Inhibitor
(pdb code 2r3i). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 2 binding sites of Fluorine where determined in the
Crystal Structure of Cyclin-Dependent Kinase 2 with Inhibitor, PDB code: 2r3i:
Jump to Fluorine binding site number:
1;
2;
Fluorine binding site 1 out
of 2 in 2r3i
Go back to
Fluorine Binding Sites List in 2r3i
Fluorine binding site 1 out
of 2 in the Crystal Structure of Cyclin-Dependent Kinase 2 with Inhibitor
 Mono view
 Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Crystal Structure of Cyclin-Dependent Kinase 2 with Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F501
b:11.1
occ:0.60
|
F24
|
A:SCF501
|
0.0
|
11.1
|
0.6
|
C19
|
A:SCF501
|
1.0
|
13.6
|
0.4
|
C23
|
A:SCF501
|
1.4
|
10.1
|
0.6
|
C20
|
A:SCF501
|
2.1
|
13.7
|
0.4
|
C11
|
A:SCF501
|
2.1
|
13.7
|
0.4
|
C22
|
A:SCF501
|
2.4
|
10.8
|
0.6
|
C11
|
A:SCF501
|
2.5
|
9.4
|
0.6
|
C07
|
A:SCF501
|
2.6
|
14.0
|
0.4
|
N06
|
A:SCF501
|
2.8
|
13.9
|
0.4
|
N06
|
A:SCF501
|
2.9
|
9.2
|
0.6
|
C07
|
A:SCF501
|
2.9
|
9.8
|
0.6
|
NZ
|
A:LYS33
|
3.2
|
11.3
|
1.0
|
O
|
A:GLN131
|
3.3
|
12.2
|
0.6
|
C21
|
A:SCF501
|
3.3
|
13.3
|
0.4
|
C23
|
A:SCF501
|
3.4
|
14.0
|
0.4
|
O
|
A:GLN131
|
3.5
|
10.8
|
0.4
|
CB
|
A:ASN132
|
3.6
|
10.5
|
1.0
|
CA
|
A:ASN132
|
3.6
|
10.2
|
1.0
|
C08
|
A:SCF501
|
3.7
|
13.8
|
0.4
|
C21
|
A:SCF501
|
3.7
|
11.3
|
0.6
|
C19
|
A:SCF501
|
3.7
|
9.9
|
0.6
|
CB
|
A:ALA144
|
3.8
|
10.3
|
1.0
|
C22
|
A:SCF501
|
3.8
|
14.1
|
0.4
|
C02
|
A:SCF501
|
4.0
|
14.3
|
0.4
|
C02
|
A:SCF501
|
4.0
|
8.9
|
0.6
|
C08
|
A:SCF501
|
4.0
|
9.6
|
0.6
|
OD2
|
A:ASP145
|
4.2
|
12.8
|
1.0
|
O
|
A:HOH1202
|
4.2
|
13.0
|
1.0
|
C
|
A:GLN131
|
4.2
|
11.5
|
0.6
|
C
|
A:GLN131
|
4.2
|
11.0
|
0.4
|
C20
|
A:SCF501
|
4.2
|
11.4
|
0.6
|
N
|
A:ASN132
|
4.3
|
10.3
|
1.0
|
CE
|
A:LYS33
|
4.5
|
11.3
|
1.0
|
OD1
|
A:ASP145
|
4.5
|
12.1
|
1.0
|
CG
|
A:ASP145
|
4.5
|
12.7
|
1.0
|
O
|
A:HOH1196
|
4.5
|
17.9
|
1.0
|
CD2
|
A:LEU134
|
4.5
|
12.3
|
1.0
|
F24
|
A:SCF501
|
4.6
|
14.2
|
0.4
|
C
|
A:ASN132
|
4.7
|
10.1
|
1.0
|
C09
|
A:SCF501
|
4.7
|
14.2
|
0.4
|
CD1
|
A:LEU134
|
4.8
|
12.5
|
1.0
|
N03
|
A:SCF501
|
4.8
|
14.4
|
0.4
|
O
|
A:HOH1190
|
4.8
|
14.6
|
1.0
|
C01
|
A:SCF501
|
4.9
|
9.5
|
0.6
|
O
|
A:HOH1193
|
4.9
|
13.1
|
1.0
|
O
|
A:ASN132
|
4.9
|
10.9
|
1.0
|
CG
|
A:GLN131
|
4.9
|
23.1
|
0.4
|
N03
|
A:SCF501
|
4.9
|
8.1
|
0.6
|
C09
|
A:SCF501
|
4.9
|
10.1
|
0.6
|
CG
|
A:LEU134
|
5.0
|
11.6
|
1.0
|
C01
|
A:SCF501
|
5.0
|
14.8
|
0.4
|
CG
|
A:ASN132
|
5.0
|
9.9
|
1.0
|
|
Fluorine binding site 2 out
of 2 in 2r3i
Go back to
Fluorine Binding Sites List in 2r3i
Fluorine binding site 2 out
of 2 in the Crystal Structure of Cyclin-Dependent Kinase 2 with Inhibitor
 Mono view
 Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Crystal Structure of Cyclin-Dependent Kinase 2 with Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F501
b:14.2
occ:0.40
|
F24
|
A:SCF501
|
0.0
|
14.2
|
0.4
|
C19
|
A:SCF501
|
1.0
|
9.9
|
0.6
|
C23
|
A:SCF501
|
1.4
|
14.0
|
0.4
|
C20
|
A:SCF501
|
2.0
|
11.4
|
0.6
|
C11
|
A:SCF501
|
2.1
|
9.4
|
0.6
|
C22
|
A:SCF501
|
2.4
|
14.1
|
0.4
|
C11
|
A:SCF501
|
2.5
|
13.7
|
0.4
|
C07
|
A:SCF501
|
2.7
|
9.8
|
0.6
|
C08
|
A:SCF501
|
3.0
|
9.6
|
0.6
|
C07
|
A:SCF501
|
3.0
|
14.0
|
0.4
|
O
|
A:ILE10
|
3.1
|
26.5
|
1.0
|
C08
|
A:SCF501
|
3.1
|
13.8
|
0.4
|
C21
|
A:SCF501
|
3.3
|
11.3
|
0.6
|
O
|
A:HOH1198
|
3.3
|
26.7
|
1.0
|
C23
|
A:SCF501
|
3.3
|
10.1
|
0.6
|
CA
|
A:GLY11
|
3.6
|
22.7
|
1.0
|
C
|
A:ILE10
|
3.6
|
25.8
|
1.0
|
CB
|
A:VAL18
|
3.7
|
14.6
|
1.0
|
CG1
|
A:VAL18
|
3.7
|
14.5
|
1.0
|
C21
|
A:SCF501
|
3.7
|
13.3
|
0.4
|
C19
|
A:SCF501
|
3.7
|
13.6
|
0.4
|
N06
|
A:SCF501
|
3.8
|
9.2
|
0.6
|
C22
|
A:SCF501
|
3.8
|
10.8
|
0.6
|
O
|
A:HOH1196
|
3.8
|
17.9
|
1.0
|
CG1
|
A:ILE10
|
3.8
|
17.6
|
1.0
|
N
|
A:GLY11
|
3.9
|
23.5
|
1.0
|
CG2
|
A:VAL18
|
3.9
|
14.6
|
1.0
|
N06
|
A:SCF501
|
4.0
|
13.9
|
0.4
|
C09
|
A:SCF501
|
4.2
|
10.1
|
0.6
|
C20
|
A:SCF501
|
4.2
|
13.7
|
0.4
|
C
|
A:GLY11
|
4.3
|
21.8
|
1.0
|
C09
|
A:SCF501
|
4.3
|
14.2
|
0.4
|
CD1
|
A:ILE10
|
4.3
|
18.2
|
1.0
|
CB
|
A:ILE10
|
4.5
|
19.3
|
1.0
|
F24
|
A:SCF501
|
4.6
|
11.1
|
0.6
|
CA
|
A:ILE10
|
4.7
|
19.6
|
1.0
|
C02
|
A:SCF501
|
4.7
|
8.9
|
0.6
|
C14
|
A:SCF501
|
4.7
|
15.8
|
0.6
|
NE2
|
A:GLN131
|
4.8
|
16.2
|
0.4
|
N03
|
A:SCF501
|
4.9
|
8.1
|
0.6
|
O
|
A:GLY11
|
4.9
|
21.0
|
1.0
|
N
|
A:GLU12
|
4.9
|
22.4
|
1.0
|
C02
|
A:SCF501
|
4.9
|
14.3
|
0.4
|
|
Reference:
T.O.Fischmann,
A.Hruza,
J.S.Duca,
L.Ramanathan,
T.Mayhood,
W.T.Windsor,
H.V.Le,
T.J.Guzi,
M.P.Dwyer,
K.Paruch,
R.J.Doll,
E.Lees,
D.Parry,
W.Seghezzi,
V.Madison.
Structure-Guided Discovery of Cyclin-Dependent Kinase Inhibitors. Biopolymers V. 89 372 2008.
ISSN: ISSN 0006-3525
PubMed: 17937404
DOI: 10.1002/BIP.20868
Page generated: Wed Jul 31 15:56:08 2024
|